WILMINGTON, DE — Incyte (Nasdaq: INCY) announced that the U.S. Food and Drug Administration has approved Opzelura (ruxolitinib) cream 1.5% for children as young as two with mild to moderate ...
More than a month since having measles, I am considered fully recovered, although my skin is still healing from the severity ...
Older adults were also more likely to arrive via emergency medical services (EMSs; 56.1% vs 34.0%; OR, 2.56; 95% CI, ...
Fall means back-to-school, football season, changing leaves — and for many people, another round of seasonal allergies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback